Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Baradzina, V. Kamishnikov (Minsk, Belarus). Essential phospholipids in pulmonary sarcoidosis. Eur Respir J 2008; 32: Suppl. 52, 3434

Member's Comments

No comment yet.

Related content which might interest you: Pathogenesis of pulmonary fibrosis in sarcoidosis Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ? Year: 2020 Differential metabolism of hyaluronic acid in patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Influence of ambroxol for the phospholipid composition of surfactant in pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 375s Year: 2002 Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 Prognostic significance of selected biomarkers in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease Source: International Congress 2014 – Sarcoidosis Year: 2014 Pulmonary hypertension in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Pulmonary hypertension associated with sarcoidosis Source: Eur Respir Mon 2012; 57: 166-181 Year: 2012 MMP7-degraded elastin is elevated in serum of patients with idiopathic pulmonary fibrosis Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 The role of free fatty acids in idiopathic pulmonary fibrosis Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017 Pulmonary hypertension in idiopathic pulmonary fibrosis: Utility of HRCT Source: International Congress 2014 – COPD and PAH related imaging Year: 2014 Surfactant protein B proforms as potential new biomarkers for idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 2 Year: 2014 Non tuberculous mycobacterial pulmonary disease in the elderly Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Eur Respir Mon 2012; 57: 148-160 Year: 2012 Cellular infiltrates of the bronchus in pulmonary sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 486s Year: 2003 Screening potential biomarkers for idiopathic pulmonary fibrosis in bronchoalveolar lavage fluid Source: International Congress 2014 – ILDs 1 Year: 2014 Non-invasive haemodynamic measurement to detect treatment response in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Chronic pulmonary aspergillosis complicating sarcoidosis Source: Eur Respir J, 49 (6) 1602396; 10.1183/13993003.02396-2016 Year: 2017 Pulmonary hypertension complicating fibrosing mediastinitis Source: International Congress 2016 – Clinic of pulmonary hypertension Year: 2016